World

EU Commission to end AstraZeneca and J J vaccine contracts at expiry - paper

The EU Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday citing a source from the Italian Health Ministry.

migrator

Updated:14th Apr, 2021 at 3:32 PM

Chennai

“The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry,” the newspaper reported.

It added that Brussels would rather focus on COVID-19 vaccines using messenger RNA (mRNA) technology, such as Pfizer’s and Moderna’s.

The European Commission is seeking clarification from J&J about the company’s “completely unexpected” announcement of delays in COVID-19 vaccine deliveries to the EU, an EU official told Reuters on Tuesday.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

EU Commission to end AstraZeneca and J J vaccine contracts at expiry - paper

The EU Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca and Johnson &amp; Johnson (J&amp;J), Italian daily La Stampa reported on Wednesday citing a source from the Italian Health Ministry.

Also Read

Tamil Nadu: Anbumani Ramadoss urges Centre to include OBC lists in caste census software

Police book agent after Tamil Nadu woman's SOS video leads to her rescue in Kuwait

Nepal flood survivors join rescue and relief operations as they grieve, search for their loved ones

Keralam CM Satheesan to take up NH safety concerns with NHAI after deaths of eight students

US envoys Witkoff, Kushner are in Moscow in new push for peace between Russia, Ukraine

The EU Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday citing a source from the Italian Health Ministry.